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Human embryonic stem cells (hESCs) have capacities to self-renew and diﬀerentiate into all cell types in vitro. Red ginseng
(RG) is known to have a wide range of pharmacological eﬀects in vivo; however, the reports on its eﬀects on hESCs are few.
In this paper, we tried to demonstrate the eﬀects of RG on the proliferation and diﬀerentiation of hESCs. Undiﬀerentiated hESCs,
embryoid bodies (EBs), and hESC-derived cardiac progenitors (CPs) were treated with RG extract at 0.125, 0.25, and 0.5mg/mL.
After treatment of undiﬀerentiated hESCs from day 2 to day 6 of culture, BrdU labeling showed that RG treatment increased
the proliferation of hESCs, and the expression of Oct4 and Nanog was increased in RG-treated group. To ﬁnd out the eﬀects
of RG on early diﬀerentiation stage cells, EBs were treated with RG extract for 10 days and attached for further diﬀerentiation.
Immunostaining for three germ layer markers showed that RG treatment increased the expressions of Brachyury and HNF3β on
EBs. Also, RG treatment increased the expression of Brachyury in early-stage and of Nkx2.5 in late-stage hESC-derived CPs. These
results demonstrate facilitating eﬀects of RG extract on the proliferation and early diﬀerentiation of hESC.
1.Introduction
Ginseng, the root of Panax Ginseng C. A. Meyer, has been
widely used in oriental medicine for over a thousand years
and is popular worldwide in alternative medicine [1, 2]. It
has been known to possess a wide range of pharmacological
eﬀects including immunomodulatory, antiaging, anticancer,
anti-inﬂammatory, antimutagenic activity and antioxidant
activity [3–7]. In addition, ginseng is reported to have eﬀects
on various heart-related diseases and to have cardioprotec-
tive action [8].
Human embryonic stem cells (hESCs), which are derived
from the inner cell mass of blastocyst, have capacities to
self-renew indeﬁnitely and diﬀerentiate into various types
of cells in vitro [9, 10]. Therefore, hESCs are considered
as a cell source for cell-based therapy and present an
ideal model for in vitro drug screening and studies of
human development. However, studies related to hESCs
have focused on diﬀerentiation into speciﬁc cell lineage
such as neurons [11], pancreatic β cell [12], cardiomyocytes
[13], and the mechanism that regulates self-renewal or
the signaling pathway for diﬀerentiation into certain cell
types. Therefore, studies about the use of hESCs or derived
diﬀerentiated cells as a developmental or preclinical model
for the screening of molecules have been performed on a
small, limited scale.
Recently, Wang et al. showed that treatment with the
total saponins of Panax ginseng promoted the proliferation
and diﬀerentiation into dopaminergic neurons of human
embryonic neural stem cells [14]. Sasaki et al. demonstrated
that treatment with a Panax ginseng compound promoted
the diﬀerentiation of mouse embryonic stem cells into
cardiomyocytes [15]. However, the eﬀects of ginseng on the
proliferation and diﬀerentiation of hESCs are still unknown.2 Evidence-Based Complementary and Alternative Medicine
Table 1: Primer sequences used for RT-PCR and qPCR.
Gene Forward Reverse bp
Pluripotency
GAPDH GGCGTTCTCTTTGGAAAGGTGTTC GTACTCAGCGGCCAGCATCG
Oct4 GAGAACAATGAGAACCTTCAGGA CTCGAACCACATCCTTCTCT
Sox2 GCGTACGCAAATTAAAGTCCAGA TGCTATTCTTCGGCCAGTTG
Nanog GCGTACGCAAATTAAAGTCCAGA TGCTATTCTTCGGCCAGTTG
Diﬀerentiation
Brachyury TAAGGTGGATCTTCAGGTAGC CATCTCATTGGTGAGCTCCCT 252
Cardiac actin TCTATGAGGGCTACGCTTTG CCTGACTGGAAGGTTAGATGG 630
HNF3β CTACGCCAACATGAACTCCA GAGGTCCATGATCCACTGGT 199
Nestin CAGCTGGCGCACCTCAAGATG AGGGAAGTTGGGCTCAGGACTGG 209
Nkx2.5 CTTCAAGCCAGAGGCCTACG CCGCCTCTGTCTTCTTCAGC 233
αMHC GTCATTGCTGAAACCGAGAATG GCAAAGTACTGGATGACACGCT 413
In this study, we tried to demonstrate the eﬀects of red
ginseng extract on hESCs proliferation and early diﬀeren-
tiation. Also, we analyzed the eﬀects of red ginseng on the
expression of cardiac related genes in hESC-derived cardiac
progenitors (CPs).
2.MaterialsandMethods
2.1. Preparation of Red Ginseng Extract. Korean red ginseng
extract derived from the root of Panax ginseng was provided
from the Korean Ginseng Corporation (Seoul, Korea).
Ginseng extract was dissolved in PBS (Invitrogen, USA) at
concentration of 50mg/ml and ﬁltered through a 0.22μm
ﬁlter (Millipore, USA). The dissolved extracts were aliquoted
a n ds t o r e da t−20
◦C until use. Extracts were added to hESCs
and diﬀerentiating cells with various concentrations—0.125,
0.25, and 0.5mg/ml.
2.2.hESCCultureandEBFormation. Thehumanembryonic
stem cell line, SNUhES3 [10], was maintained as previously
reported [16]. Brieﬂy, hESCs were cultured on mitotically
inactivated STO (CRL-1503; ATCC, USA) feeder layer by
mechanical dissociation. hESC culture medium consisted of
DMEM/F12 (Invitrogen), 20% knockout serum replacement
(KO-SR; Invitrogen), 1% nonessential amino acids (Invitro-
gen), 50 U/ml penicillin (Invitrogen), 50μg/ml streptomycin
(Invitrogen), 0.1mM β-mercaptoethanol (Sigma, USA), and
4ng/ml basic ﬁbroblast growth factor (bFGF; Invitrogen).
For EB formation, undiﬀerentiated hESCs were treated
with Collagenase type IV (Invitrogen) for 30min at 37
◦C.
Dissociated hES colonies were centrifuged and washed with
PBS. Washed hES colonies were transferred and cultured in
suspension for several days.
2.3. Diﬀerentiation of hESC into Cardiac Progenitors. Undif-
ferentiated hESCs were treated with 0.025% trypsin-EDTA
(Invitrogen) for 3min at 37
◦C. Feeder cells were gently
removed and washed with PBS (Invitrogen). hES colonies
were then treated with 100ng/ml Activin A (R&D Systems,
Minneapolis, MN, USA) for 24hr and then 10ng/ml BMP2
(R&D Systems) for another 4 days in RPMI 1640 (Invitro-
gen), supplemented with B27 (Invitrogen). The cytokines
were removed at day 5 and medium was exchanged every
other day during the diﬀerentiation period.
2.4. Measurement of hESC Colony Size. To calculate the
average size of hESC colonies, clumps were replated in
fresh feeder layer when subcultured. Four and six days after
subculture,thediametersof20coloniesweremeasuredusing
i Solution Image Capture Program (Seoul, Korea).
2.5. BrdU Labeling Analysis. Cells were labeled with 10μM
5-bromo-2-deoxyuridine (BrdU, Roche Diagnostics, Ger-
many) for 24hrs to assess proliferation of RG-treated
hESCs. After labeling, hESCs were detached from the feeder
layer using 0.5mg/ml dispase (Invitrogen) and detached
colonies were treated with 0.25% trypsin-EDTA (Invitrogen)
for 5min at 37
◦C to dissociate into single cells. Single
cells were ﬁxed with 70% EtOH for 30min at RT and
denatured with 4M HCl (Sigma) for 10min at RT. Following
incubation with 3% BSA soln. containing 0.03% Triton X100
(Sigma), cells were treated with mouse anti-BrdU antibody
(Chemicon, USA) for 50min at RT. After washing twice
with PBST, the cells were incubated with Alexa Fluor 488-
labeled donkey antimouse IgG antibody (Molecular Probes)
for 40min at 37
◦C, and then washed three times with PBST.
Next, Propidium Iodide (Sigma) was added to the cells and
incubated for 30min at RT. Samples were analyzed using BD
FACS Calibur (BD Sciences, USA).
2.6. RT-PCR and qPCR. T o t a lR N A sw e r ee x t r a c t e df r o m
the cells using Trizol (Invitrogen) according to the manu-
facturer’s instructions. cDNAs were synthesized from 1μg
of RNA using Accute RT-premix (Bioneer, Korea). Primers
used for RT-PCR and qPCR are listed in Table 1.P C Rw a s
performed by 30 cycles of denaturation at 95
◦Cf o r3 0s e c ,
annealing at 56
◦C for 30sec and extension at 72
◦Cf o r3 0s e c .
PCR products were visualized in 2% agarose gel.Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Morphological observation and measurement of colony diameter of undiﬀerentiated hESCs after RG treatment. (a) hESCs were
treatedwith0,0.125,0.25, and0.5mg/mlofRGextractfromday 2today7. (b)Undiﬀerentiated hESC colonydiameter was calculated under
the microscopic observation. Twenty colonies of each group were measured for the calculation of average diameter of hESC colony.
Quantitative PCR was carried out in RotorGene 3000
(Corbett Life Science, Sydney, Australia) using QuantiTect
SYBR green PCR kit (Qiagen, Valencia, CA, USA). The
ampliﬁcation program included an initial step at 95
◦Cf o r
15min, followed by 45 cycles of denaturation at 95
◦C
for 15sec, annealing at 58
◦C for 20sec and extension at
72
◦C for 30sec. All reactions were run in triplicate. CT
was calculated under default settings for the RotorGene 6.0
program (Corbett Life Science). Relative gene expression was
normalized to GAPDH expression.
2.7. Immunoﬂuorescence Staining. Samples were ﬁxed with
4% paraformaldehyde (PFA; Sigma) for 30min at RT.
After washing with PBS, 3% BSA soln. containing 0.3%
triton X100 (Sigma) was treated at 4◦C overnight. Sam-
ples were then incubated with the primary antibodies,
mouse antihuman Nestin (R&D Systems), rabbit antihuman
Brachyury (SantaCruz Biotechnology, USA) and goat anti-
human HNF3β (SantaCruz Biotechnology) for 1hr at RT.
After washing with PBST, incubations with the secondary
antibodies, Alexa Fluor 488-labeled donkey antigoat and
rabbit IgG, Alexa Fluor 594-labeled donkey antimouse IgG,
were performed for 50min at RT. Samples were washed with
PBST, and mounting soln. containing DAPI (Vectorshield,
USA) was added. Samples were observed using a confocal
laser microscope (BioRad, USA).
3. Results
3.1. RG Extract Treatment Enhances Proliferation of hESCs.
To analyze the eﬀects of ginseng, undiﬀerentiated hESCs
weretreatedwith0.125,0.25,and0.50mg/mlconcentrations
of RG extract from day 2 to day 6. RG-treated hESC colonies
were enlarged in size compared to untreated hESCs
(Figure 1(a)). Average diameters of both day 4 and day 64 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Proliferation and expression of pluripotency markers in RG extract-treated hESCs. (a) BrdU incorporation of RG-treated hESCs.
Undiﬀerentiated hESCs were preincubated with BrdU and analyzed by FACS. (b) Expression of stemness-related genes was evaluated by
qPCR.
hESCs increased in the RG-treated group compared to the
control group (Figure 1(b)). To assess the proliferative eﬀect,
the BrdU-positive population was quantiﬁed. Compared to
the control, there was an increase in proliferating cells in the
RG-treated group. Proportion of positive cells were 80.8%,
83.3%, and 84.4% in 0.125, 0.25, and 0.5mg/ml RG-treated
groups, respectively (Figure 2(a)). These results showed that
RG extract increased the proliferation of hESCs.
To ﬁnd out the eﬀect of RG extract on pluripotency
of hESCs, the expressions of Oct4, Sox2, and Nanog were
evaluated. Undiﬀerentiated hESCs generally proliferate and
express high level of pluripotency markers. Expression
of Oct4 was slightly increased in the RG-treated group.
Expressions of Sox2 and Nanog were also increased in RG-
treated group (Figure 2(b)). These results indicated that RG
extracts also aﬀected the expression level of pluripotency
markers in undiﬀerentiated hESCs.
3.2. Enhanced Diﬀerentiation into Mesendoderm at Embryoid
Body Stage. To evaluate the eﬀects of RG extract on hESCs
diﬀerentiation, RG extract was added to embryoid bodies in
suspension culture for 10 days (Figure 3(a), upper panel).
After 10 days of suspension, EBs were reattached for
further diﬀerentiation (Figure 3(a), lower panel). RT-PCR
results showed that expression of Brachyury and HNF3β
was upregulated in the RG-treated group (Figure 3(b)).
Immunostaining results also showed that RG treatment
increased the expression of three germ layer markers,
Nestin, Brachyury, and HNF3β, compared to the controls
(Figure 3(c)). Interestingly, expressions of Brachyury and
HNF3β were signiﬁcantly upregulated in the RG-treated
group. These results indicated that RG treatment of reat-
tached EBs promoted the early phase diﬀerentiation of
hESCs into mesendoderm lineage.
3.3. Upregulated Cardiac Lineage Gene Expressions in hESC-
Derived CPs. Eﬀects of RG extract on cardiac speciﬁc lineage
diﬀerentiation were also evaluated. Diﬀerentiated cells of day
0to4(earlystage)andofday14to18(latestage)weretreated
with RG extract. Treatment with RG signiﬁcantly enhanced
the expression of Brachyury and of Nkx2.5 in early stage CPs
(Figure 4(a)). Also, the expression of cardiac actin, another
cardiac lineage speciﬁc marker, was also increased in RG-
treated early stage CPs. At day 3 and day 15, the expressions
of speciﬁc proteins were examined. Brachyury, Nkx2.5, and
cardiac troponin (Tn) I showed increased expressions in theEvidence-Based Complementary and Alternative Medicine 5
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Figure 3:ExpressionsofthreegermlayermarkersinRG-treated,diﬀerentiatedcells.After20daysoftreatment,expressionofearlyectoderm,
mesoderm,andendodermmarkerswereevaluated.RG-treateddiﬀerentiatedcellsshowedmoredominantexpressionofmesodermalmarker,
Brachyury and endodermal marker, HNF3β. (a) Morphological observation of diﬀerentiating cells in suspension and attached state. (b)
Expressions of three germ layer markers in reattached, RG-treated cells. (c) Immunostaining results of ectoderm (Nestin), mesoderm
(Brachyury) and endoderm (HNF3β).6 Evidence-Based Complementary and Alternative Medicine
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Figure 4:mRNAandproteinexpressionsofmesodermalandcardiacmarkersinhESC-derivedCPs.(a)mRNAexpressionofcardiac-speciﬁc
markers in RG-treated, hESC-derived CPs. Expressions of Brachyury, Nkx2.5, αMHC, and cardiac actin were conﬁrmed by RT-PCR. 1μg
of RNAs were used for synthesis of cDNA. (b) Protein expression of Bachyury (early stage), Nkx2.5 and cardiac troponin I (late stage) in
hESC-derived CPs.
RG-treated group (Figure 4(b)). These results demonstrated
that treatment with RG extract aﬀected the expression of
cardiac-related genes and promoted the diﬀerentiation of
hESC-derived diﬀerentiated cells.
4. Discussion
Red ginseng is a popular herbal medicine with a long history
of use in Asia and has a variety of therapeutic eﬀects [17,
18]. The main component of ginseng is ginsenoside which
belongs to the steroid family named dammarane saponins
[17, 19]. Several studies have demonstrated the eﬀect of
ginseng on certain diseases using in vitro models. However,
the evidence for the pharmacological eﬀects of ginseng is
still limited. Therefore, demonstrating the pharmaceutical
activity of ginseng on a preclinical or clinical human model
would be helpful in providing evidence for the eﬀects of
herbal medicine.
The eﬀect of red ginseng or ginseng extract on cell prolif-
eration or diﬀerentiation has been previously demonstrated.
Zuo et al. reported that total saponins of Panax Ginseng
inducedK562cellstodiﬀerentiateintoerythrocytes[20],and
Popovichetal.showedginsengincreasedviabilityofcultured
cell [21]. In addition, Lei et al. reported that the Panax gin-
seng extract promoted the migration of vascular endothelial
cells and expression of vascular endothelial growth factor
(VEGF) mRNA [22]. Another group demonstrated that
treatment with ginseng extract enhanced the contractility
of mouse embryonic stem cell-derived cardiomyocytes [15].
Even with these studies, in the scientiﬁc literature to date,Evidence-Based Complementary and Alternative Medicine 7
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Figure 5: Schematic presentation on the various eﬀects of red ginseng extract on the proliferation and diﬀerentiation of hESC, embryoid
body and hESC-derived cardiac progenitor. hESC: human embryonic stem cells, RGE: red ginseng extract.
the use of ginseng or red ginseng as gene expression-
regulating factors in hESCs is extremely rare. To our
knowledge, our current paper is the ﬁrst to observe the
facilitating eﬀects of ginseng on the proliferation and
diﬀerentiationofhESCs.Thisisimportantinformationsince
the aforementioned beneﬁcial eﬀects have been identiﬁed in
humanstemcells,whichprovidesthebasisforfurtherstudies
to evaluate the long-term eﬀects of RG.
hESCs usually proliferate unlimitedly in vitro without
lossofpluripotency[9].ManyparacrinefactorssuchasFGF2
contributetothemaintenanceofstemnessinhESCs[23–25].
Ginseng is known as a cardiotonic factor for cardiomyocytes
[26] and regulator of cardiac contraction [27]. To determine
the eﬀects of RG extract, we observed the morphology after
RG-treatment, based on the general tendency of hESCs to
alternate their morphology after treatment with inducing or
soluble factors. RG-treated hESCs showed larger colony size,
increased in proliferation and expression of pluripotency
markers. RG extract also promoted diﬀerentiation into
mesendoderm lineage at embryoid body stage, which is
evaluated by the increased expression of Brachyury and
HNF3β. It may imply that ginseng extract could aﬀect the
cell diﬀerentiation at embryoid body stage. In addition,
RG treatment increased the expression of Brachyury, an
early mesendodermal marker, at the earlier stage of hESC-
derived CPs and Nkx2.5, a cardiac-speciﬁc marker, at later
stage of hESC-derived CPs. These results suggest that RG
extracts have diverse eﬀects according to the diﬀerent stages
of undiﬀerentiated hESCs and diﬀerentiating cells.
Intriguingly, we observed that diﬀerent eﬀects of RG
were observed at the diﬀerent stages of undiﬀerentiated
hESCs in diﬀerentiating cells. RG extract treatment led
to an accelerated proliferation of undiﬀerentiated hESCs,
a n dp r o m o t e dt h ed i ﬀerentiation of EBs into mesendoderm
lineage (Figure 5). Further studies are needed to determine
the eﬀects of each RG component or its combinations, which
may be able to explain the various eﬀects of RG extract
observed in our study.
In conclusion, this pilot study tried to evaluate the eﬀects
of RG extracts on the proliferation and diﬀerentiation of
hESCs during short-term culture in vitro. From our results,
RG extracts promoted the proliferation of undiﬀerenti-
ated hESCs, preferentially promoted diﬀerentiation of EBs
into mesendoderm lineage, and upregulated cardiac-speciﬁc
expression on hESC-derived cardiac progenitors.
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